10-K · June 25, 2026
Anterix Inc. demonstrated strong financial recovery in FY2026, with net income reaching $90.6 million, an increase of 897% from a loss of $11.4 million in FY2025. The company successfully executed revenue growth of 8%…
Earnings analysis · 10-Q
Filed August 11, 2026 · Our reading of the company's report
The latest report
Anterix delivered a mixed quarter: diluted EPS of $0.01 exceeded the $(0.25) consensus estimate, while $1.958 million of revenue missed consensus by $19,200. Operating cash flow improved by $5.185 million year over year…
Anterix delivered a mixed quarter: diluted EPS of $0.01 exceeded the $(0.25) consensus estimate, while $1.958 million of revenue missed consensus by $19,200. Operating cash flow improved by $5.185 million year over year to $2.045 million, and liquidity remained strong with $116.0 million of cash and no debt. The filing provided no new EPS or revenue guidance; approximately $9.6 million of customer proceeds are expected during the remainder of fiscal 2027, but timing remains unpredictable. The filing states that there were no material changes to the risk factors disclosed in the 2026 Annual Report.
Diluted EPS was $0.01, a $0.26 beat versus the $(0.25) consensus estimate. The result was also below the prior reported quarter’s $0.98 diluted EPS.
Revenue was $1.958 million, $19,200 below the $1.9772 million consensus estimate, but increased year over year from the prior reported period.
Operating cash flow improved to $2.045 million from $(3.140) million year over year, a $5.185 million improvement.
Cash and cash equivalents were $116.0 million, and the company reported no debt, supporting liquidity for continued spectrum commercialization.
Approximately $9.6 million of customer proceeds are expected during the remainder of fiscal 2027, although management noted that the timing of customer proceeds is unpredictable.
Gross margin was 100.0% in the reported quarterly history, consistent with the company’s asset-light revenue model.
Management states that the timing of customer proceeds is unpredictable; approximately $9.6 million is expected during the remainder of fiscal 2027, creating potential cash-flow and commercialization timing risk.
The company’s primary market-risk exposure is interest-income sensitivity; a 10% change in market interest rates is not expected to materially affect results, but lower rates could reduce interest income on the $116.0 million cash balance.
The company’s $250.0 million share-repurchase authorization had $226,672 of remaining capacity at June 30, 2026, but no shares were repurchased during the quarter. Capital allocation is dependent in part on unpredictable customer-contract proceeds.
No numeric revenue or EPS guidance was provided. Management reported approximately $9.6 million of customer proceeds expected during the remainder of fiscal 2027; timing remains unpredictable.
Anterix Inc. demonstrated strong financial recovery in FY2026, with net income reaching $90.6 million, an increase of 897% from a loss of $11.4 million in FY2025. The company successfully executed revenue growth of 8%…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.